Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate
Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate
Surface Oncology 第二季度每股收益 (0.46) 低於預期 (0.34)
Surface Oncology (NASDAQ:SURF) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.34) by 35.29 percent. This is unchanged from the same period last year.
Surface Oncology（納斯達克股票代碼：SURF）公佈的季度每股虧損爲0.46美元，比分析師共識估計的0.34美元（0.34美元）低35.29％。這與去年同期相比沒有變化。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。